Skip to main content
. 2013 Oct 25;2(5):e000360. doi: 10.1161/JAHA.113.000360

Figure 9.

Figure 9.

Effect of pravastatin on events after adjustment for changes in Lp‐PLA2 activity and LDL cholesterol (LDL‐C).9 Baseline and change in LDL‐C and Lp‐PLA2 activity are expressed as continuous variables. CHD indicates coronary heart disease; CVD, cardiovascular disease; HR, hazard ratio; Lp‐PLA2, lipoprotein‐associated phospholipase A2; MI, myocardial infarction; RRR, relative risk reduction.